BASF doubles its production capacity for Softex® at its Cimanggis site, Indonesia

Published on 19 April 2022

As part of the efforts to support the increasing demand for medical gloves globally due to COVID-19 pandemic, BASF is planning to double its Softex® production capacity at its Cimanggis site in Indonesia. This expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry that are playing a very pivotal role during the COVID-19 pandemic.

Softex dispersion is a critical material used in medical exam glove production, and it is being recognized throughout the APAC region for helping glove producers to deliver high quality gloves.

“Since its establishment in 1979, the Cimanggis site is an important production facility for the region. BASF has also upgraded its facilities to enable the supply of high-quality materials used in the production for medical gloves. The COVID-19 pandemic has driven a high demand for medical gloves globally, from 340 billion pieces in 2019 to 500 billion pieces in 2021¹. And BASF remains committed to support customers and societal needs, especially during this period,” said Dr. Laszlo Szarvas, Vice President, Business Management Home Care, I&I and Industrial Formulators, Care Chemicals, BASF Asia Pacific.

Read More


This site doesn't support mobile landscape mode.
Please rotate back to portrait mode.